Montes Archimedes Acquisition (MAAC) Taking Roivant Sciences Public In $7.3 Billion Deal
By Amit Chowdhry ● May 3, 2021
Roivant Sciences (a biopharmaceutical and healthcare technology company) and Montes Archimedes Acquisition Corp. (Nasdaq: MAAC), a special purpose acquisition company (SPAC) sponsored by Patient Square Capital, today announced that they have entered into a definitive business combination agreement. These are the details.